Collinsella vaginalis

Information

Microbe Identification

Collinsella vaginalis

Microbe id: PMDBM2021493
Level: Species
NCBI Taxonomy ID:
Taxonomy Species: Collinsella vaginalis [1870987]
Taxonomy Genus: Collinsella [102106]
Taxonomy Family: Coriobacteriaceae [84107]

Interactions between microbe and active substances


ⓘ How do we work out MGCs and BGCs of one specific species?


Metabolic gene clusters of Collinsella vaginalis

No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View gutSMASH Detailed Result
Biosynthetic gene clusters of Collinsella vaginalis


No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View antiSMASH Detailed Result
Map of Collinsella vaginalis distribution in human body and influence of diseases distribution in human body and influence of diseases


ⓘ How do you use the microbe distribution map?
ⓘ How did we get the relative abundance and microbe change in the map?
bodymap Oral Nose Esophagus Stomach Trachea Upper respiratory tract Vagina Blood Urethral Lung Cervix Rectum Skin Duodenum Fallopian tube Fallopian tube Peritoneal fluid Uterus Ear Ovary Ovary Colon Ileum Cecum
Disease id Bodysite Relative abundance (%) Disease name Microbe_change

Relative abundance landscape of Collinsella vaginalis in human gut microbiota samples



Abundance lanscape in healthy samples (by patients' age)
Abundance lanscape in healthy samples (by patients' country)
Abundance lanscape in disease samples
⚠ About the relative abundance profile

The relative taxonomical abundance data (pre-processed using a unified analysis pipeline) was retrieved from curatedMetagenomicData resource [Edoardo Pasolli, et al. Nat Methods. 2017;14(11):1023-1024]. Data retrieved here was pre-processed as unified relative abundance: at each taxonomic level (e.g., species, genus, family), the sum of microbial abundance of individual microbiota sample was 1, and relative abundance of each microbe was log10 transformed [relative abundance ranges from -7 to 0].

Healthy samples and disease samples (only disease types with >= 20 samples were included) were grouped by age periods, patients?country, or disease type to plot the relative abundance landscape using ggplot2 R package.



Comparative analysis of human gut metagenomes between disease and healthy samples of Collinsella vaginalis

Data source: Phenotype comparisons were obtained from GMrepo . We summarized all comparisons that included healthy samples as controls and overlapped with microbes represented in MASI.

Note: LDA scores below 0 indicate taxa enriched in healthy samples, whereas scores above 0 indicate taxa enriched in disease samples.

Disease Project ID LDA score Experiment Type
Kidney Failure, Chronic PRJNA449784🔗3.0858322944313mNGS
Kidney Failure, Chronic PRJEB65297🔗3.7479051110677mNGS
Hemangioma, Cavernous PRJNA629755🔗-3.01966192495804mNGS
Hypertension PRJNA509999🔗-3.29954637338514mNGS
Diabetes Mellitus, Type 2 PRJNA588353🔗2.5601923580676216S
Diabetes Mellitus, Type 2 PRJDB9608🔗4.7112149191304316S
Diarrhea PRJNA317326🔗-3.6351067603727116S
Diarrhea PRJEB14038🔗-3.00567928765251mNGS
Dwarfism PRJNA819198🔗-4.2273743008267316S
Colorectal Neoplasms PRJNA986175🔗-3.9504643867920816S
Colorectal Neoplasms PRJNA936589🔗-3.5990282889476mNGS
Colorectal Neoplasms PRJNA1167935🔗-3.52209669562703mNGS
Colorectal Neoplasms PRJEB53415🔗3.866252021330616S
Colorectal Neoplasms PRJNA1050885🔗3.91881169116337mNGS
Parkinson Disease PRJNA742875🔗3.6638651755816716S
Colitis, Ulcerative PRJNA820056🔗-3.8506450237656316S
Colitis, Ulcerative PRJNA398089🔗3.0898105189439mNGS
Colitis, Ulcerative PRJNA993675🔗3.15366475577853mNGS
Campylobacter Infections PRJNA660443🔗-3.1735510492496mNGS
Spinal Cord Injuries PRJNA861246🔗-3.9807729692821216S
Osteoporosis, Postmenopausal PRJNA631117🔗-3.8974712884657716S
Carcinoma, Renal Cell PRJNA842560🔗3.4635688442863516S
Esophageal Neoplasms PRJNA698746🔗3.5970318974675416S
Helicobacter Infections PRJDB10599🔗3.8617813588901316S
Caliciviridae Infections PRJNA788674🔗-4.119566823772716S
Feeding and Eating Disorders PRJEB55035🔗-4.3395439688909316S
Lymphoma, Large B-Cell, Diffuse PRJNA906033🔗-3.6426625270833216S
Prostatic Neoplasms PRJNA762994🔗-3.9058843592998616S
Asthma PRJEB23348🔗-4.2557876838845416S
Asthma PRJEB59709🔗-3.54358260018005mNGS
Crohn Disease PRJNA917086🔗-4.2630492788486416S
Crohn Disease PRJNA938107🔗-4.0683752256396716S
Crohn Disease PRJNA820056🔗-3.7056349718281616S
Crohn Disease PRJNA793776🔗-3.61078373550548mNGS
Crohn Disease PRJEB42155🔗-3.55833523714761mNGS
Crohn Disease PRJNA429990🔗-2.51961342409331mNGS
Crohn Disease PRJNA993675🔗3.2988988287295mNGS
Polycystic Ovary Syndrome PRJNA530971🔗-3.57064457107046mNGS
Cholestasis PRJNA478781🔗-3.5767494189509216S
Appendicitis PRJDB8606🔗-3.5913258099711716S
Anorexia PRJNA674716🔗-3.43529661728201mNGS
Hepatitis C PRJNA1070593🔗-3.5748828007055116S
Neuroblastoma PRJEB63351🔗3.47829409903835mNGS
Hematologic Neoplasms PRJNA777832🔗-3.3042294909088316S
Irritable Bowel Syndrome PRJNA637763🔗-3.9149283227468316S
Irritable Bowel Syndrome PRJEB37924🔗3.78660415286717mNGS
IgA Deficiency PRJNA967340🔗-2.8453184642545916S
Depressive Disorder, Major PRJNA762199🔗4.09850947202046mNGS
Lung Neoplasms PRJNA507734🔗-4.0683932058896816S
Lung Neoplasms PRJNA736821🔗3.488314042662716S
Liver Cirrhosis PRJNA861246🔗-3.9409454802999916S
Liver Cirrhosis PRJNA872871🔗4.034631399436216S
HIV Infections PRJNA810567🔗-3.6698642658839416S
HIV Infections PRJNA408085🔗3.1855044397391816S
HIV Infections PRJDB11949🔗4.3861309479439516S
Autism Spectrum Disorder PRJEB42687🔗2.8980369612316216S
Autism Spectrum Disorder PRJEB45948🔗4.0975004513711516S
Hand, Foot and Mouth Disease PRJNA1017976🔗-4.6156137219870216S
Rhinitis, Allergic PRJNA692671🔗-4.4660728408047516S
Renal Insufficiency, Chronic PRJNA562327🔗3.4244740821957616S
Renal Insufficiency, Chronic PRJEB65297🔗3.79204181584421mNGS
Malaria PRJNA642859🔗-3.2993238388760116S
Breast Neoplasms PRJNA658160🔗-2.6356951881729716S
COVID-19 PRJNA624223🔗-4.36658010474308mNGS
COVID-19 PRJNA689961🔗-4.32037067195628mNGS
COVID-19 PRJNA769052🔗-4.1583352909784616S

Microbe-Therapeutic Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of therapeutic substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of therapeutic substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Therapeutic substance that metabolized by Collinsella vaginalis



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Therapeutic Substances that affect the Collinsella vaginalis



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)


Drug involved metabolizing or transporting reactions that are carried out by Collinsella vaginalis

No data available!

ⓘ How do we get these drug reactions?

To obtain the reactions associated with therapeutic substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331] database.
Identifying Drug-Associated Reactions: Next, we extracted all reactions that are linked to therapeutic substances from these reconstructions. This involved filtering and identifying reactions specifically related to drug metabolism and transport.
Linking Reaction to Microbes: Utilizing the identified reaction related genes (UidA, Tdc etc.), we machted the corresponding drug-associated reactions to existing microbes in the reconstructions in AGORA2. We could link the presence of these genes in different microbes to the potential for those microbes to carry out the corresponding drug-related reactions.
Putative Drug Reactions: As a result, the drug reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with therapeutic substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGORA2)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGORA2, allowing access to the original .mat files. For more details, visit the AGORA2 repository.

# Model Download
No records found

Detailed Information of drug reactions

Metabolism
Transport
Drug Substrate Drug Metabolite Gene responsible for the reaction Reaction Description Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Substance Name Gene responsible for the reaction Reaction Description Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Herbal Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of herbal substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of herbal substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Traditional medicines/herbs/herbal compounds that metabolized by Collinsella vaginalis


Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Traditional medicines/herbs/herbal compounds that affect the Collinsella vaginalis



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)

Microbe-Dietary Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of dietary substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of dietary substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGREDA [Ref:Nature Communications, 12 (2021) 4728]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Dietary Substances alter the abundance of Collinsella vaginalis

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)





Dietary substance that metabolized by Collinsella vaginalis

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)




Dietary Substance involved metabolizing or transporting reactions that are carried out by Collinsella vaginalis

ⓘ How do we get these diet reactions?

To obtain the reactions associated with dietary substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGREDA [Ref:Nature Communications, 12 (2021) 4728] database.
Identifying Diet-Associated Reactions: Next, we extracted all reactions that are linked to dietary substances from these reconstructions. This involved filtering and identifying reactions specifically related to dietary substance metabolism and transport.
Linking Reactions to Microbes: Using the identified related genes (e.g., UidA, Tdc) for each drug metabolite reaction, we matched these reactions to microbes possessing the corresponding genes. This allowed us to link the presence of these genes in different microbes to their potential for carrying out the associated drug-related reactions.
Putative Drug Reactions: As a result, the diet reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with dietary substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGREDA)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGREDA, allowing access to the original .xml files. For more details, visit the AGREDA repository.

# Model View
No records found

Detailed Information of diet reactions

Metabolism
Transport
Diet Substrate Enzyme Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Dietary Substance Name Reaction Name Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Environmental Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of environmental substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of environmental substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Environmental Substances that metabolized by Collinsella vaginalis



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Environmental Substances that affect the Collinsella vaginalis


Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)
ⓘ Background And User Guideline

Microbe Taxonomy level Species Quorum Sensing (QS) Language QS Language Class Total No. of QS Languages of the Species Reference (PubMed ID)


Diseases associated with the microbe Collinsella vaginalis


No data available

Microbiota Site Disease Name Disease Association Class Disease Associated Abundence Change Reference (PubMed ID)



Landscape of Bacteria-Substance-Disease Interaction/Association Network



ⓘ How is the network built?